Developing a novel class of neuroplasticity-promoting therapeutics

all companies
milestones

Founded 2019

Partnered 2021

Team

Mark Rus

David Olson

Board
LEAD INVESTOR
category
Neurology + Mental Health
Aging

Broadening patient access to safe, fast-acting, and long-lasting medicines for brain disorders including treatment-resistant depression, PTSD, neurodegeneration, and more

No items found.